Quantinno Capital Management’s Core Laboratories CLB Stock Holding History

Quantinno Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$754K	Sell	64,741 -3,654	-5%	-$52.2K	﹤0.01%	2762
2026 Q1	$1.15M	Buy	68,395 +338	+0.5%	+$6.05K	﹤0.01%	2042
2025 Q4	$1.09M	Buy	68,057 +36,325	+114%	+$541K	﹤0.01%	1734
2025 Q3	$392K	Buy	31,732 +10,693	+51%	+$125K	﹤0.01%	2230
2025 Q2	$242K	Buy	+21,039	New	+$250K	﹤0.01%	2190
2025 Q1	–	Sell	-11,294	Closed	-$195K	–	2109
2024 Q4	$195K	Buy	+11,294	New	+$218K	﹤0.01%	1547
2020 Q1	–	Sell	-6,258	Closed	-$236K	–	397
2019 Q4	$236K	Buy	+6,258	New	+$281K	0.15%	337

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Quantinno Capital Management's CLB Position: Q2 2026 in Review

Quantinno Capital Management reduced its Core Laboratories (CLB) stake by 5.3% in Q2 2026, selling an estimated $52.2K and leaving 64,741 shares worth $754K. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

Quantinno Capital Management first reported a position in CLB in Q4 2019 and has held it in 7 quarters since. The position peaked at $1.15M in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Quantinno Capital Management held 64,741 shares of Core Laboratories worth $754K as of Q2 2026.
Quantinno Capital Management sold 3,654 Core Laboratories shares in Q2 2026, an estimated $52.2K.
Core Laboratories made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2762 holding.
Quantinno Capital Management first reported a position in Core Laboratories in Q4 2019 and has held it in 7 quarters since.
Quantinno Capital Management's Core Laboratories position peaked at $1.15M in Q1 2026.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.